Purslane Seed Oil: A Promising Adjuvant for Doxorubicin in Ehrlich Ascites Carcinoma Therapy | ||||
| Alfarama Journal of Basic & Applied Sciences | ||||
| Articles in Press, Accepted Manuscript, Available Online from 13 February 2024 | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ajbas.2024.261360.1207 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Ibrahim Samy kamel  1; Mohamed Samy El-Ghareeb2; Mona Samy Guida3; Hatem Abdelmenem El-Mezayen4; lamia Abdelhameed Ismail5
| ||||
| 1Department of Chemistry, Faculty of Science, Port Said University | ||||
| 2Department of chemistry, Faculty of science, Port Said university | ||||
| 3University Children Hospital, Faculty of Medicine, Mansoura University, Mansoura, Egypt | ||||
| 4Department of Chemistry, Faculty of Science, Helwan University, Helwan, Egypt | ||||
| 5chemistry department, faculty of science, Portsaid university | ||||
| Abstract | ||||
| Purslane seed oil (PSO) is a herbal extract with antioxidant and anti-inflammatory properties that may enhance the efficacy and reduce the toxicity of doxorubicin (DOX), a potent anticancer drug. This study investigated the effects of PSO and DOX on the cell cycle and kidney and liver function in Ehrlich ascites carcinoma (EAC) mice, a widely used experimental model of cancer. Forty female mice were randomly assigned to five equal groups (n = 8/group) with distinct treatment regimens: control, EAC control, EAC+PSO, EAC+DOX, and EAC+PSO+DOX. After EAC cell injection (2x10⁶), mice received 3 weeks of treatment with PSO (200 mg/kg/day) and DOX (4 mg/kg/week). The cell cycle analysis and biochemical assays performed on EAC-bearing mice showed that PSO and DOX exerted different and synergistic effects on the cell cycle and apoptosis of EAC cells, and that their combination reduced the deterioration of the kidney and liver function parameters in EAC-bearing mice. These findings suggest that PSO could be a potential complementary agent to DOX in the treatment of EAC and other cancers, as it could enhance the antitumor and organ-protective effects of DOX. | ||||
| Keywords | ||||
| Portulaca oleracea L; Extract; Ehrlich Ascites carcinoma; Cell cycle; Doxorubicin | ||||
|
Statistics Article View: 35 |
||||
